Wenzel, Ulrich O <br/><br/>
Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.  [electronic resource] 

 -  Kidney international  Mar 2002 
 - 1020-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1046/j.1523-1755.2002.00192.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II--administration & dosage<br/>Animals<br/>Cell Cycle Proteins--metabolism<br/>Cell Division--drug effects<br/>Complement C3--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Extracellular Matrix--metabolism<br/>Glomerulonephritis, Membranoproliferative--metabolism<br/>Immunoglobulin G--metabolism<br/>Infusion Pumps<br/>Kidney Glomerulus--metabolism<br/>Macrophages--pathology<br/>Male<br/>Monocytes--pathology<br/>Norepinephrine--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Angiotensin, Type 1<br/>Receptor, Angiotensin, Type 2<br/>Receptors, Angiotensin--physiology<br/>Transforming Growth Factor beta--metabolism<br/>Tumor Suppressor Proteins--metabolism<br/>Vasoconstrictor Agents--administration & dosage